Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.94 USD | -5.38% | -3.88% | -5.71% |
04-01 | Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-26 | Transcript : Quince Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-5.71% | 42.93M | |
+25.90% | 42.68B | |
-3.90% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.67% | 24.94B | |
-21.62% | 18.96B | |
+27.75% | 12.3B | |
-2.96% | 11.95B | |
-1.88% | 11.55B |
- Stock Market
- Equities
- QNCX Stock
- News Quince Therapeutics, Inc.
- HC Wainwright Adjusts Cortexyme's Price Target to $15 From $30, Reiterates Buy Rating